PRYGOCKI MARK A SR 4
4 · Verrica Pharmaceuticals Inc. · Filed Jun 14, 2019
Insider Transaction Report
Form 4
PRYGOCKI MARK A SR
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-12+5,834→ 5,834 totalExercise: $8.93Exp: 2029-06-12→ Common Stock (5,834 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 12, 2019 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date.